[
  {
    "ts": null,
    "headline": "Tracking Al Gore's Generation Investment Management Portfolio - Q3 2025 Update",
    "summary": "Read here for Generation Investment Managementâs latest Q3 2025 portfolio updates, top stock holdings, and key investment moves.",
    "url": "https://finnhub.io/api/news?id=9b35de4c8080df6967c3b7149780479ef91e2900fd669dac3a6a3600cb76d0b6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762815158,
      "headline": "Tracking Al Gore's Generation Investment Management Portfolio - Q3 2025 Update",
      "id": 137427601,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534971566/image_534971566.jpg?io=getty-c-w1536",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "Read here for Generation Investment Managementâs latest Q3 2025 portfolio updates, top stock holdings, and key investment moves.",
      "url": "https://finnhub.io/api/news?id=9b35de4c8080df6967c3b7149780479ef91e2900fd669dac3a6a3600cb76d0b6"
    }
  },
  {
    "ts": null,
    "headline": "SOLV or DHR: Which Is the Better Value Stock Right Now?",
    "summary": "SOLV vs. DHR: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=0d54214358b5361617a6a670eaef89267cc44d2e4e28ad8ce5f436cde308b3c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762792806,
      "headline": "SOLV or DHR: Which Is the Better Value Stock Right Now?",
      "id": 137396697,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "SOLV vs. DHR: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=0d54214358b5361617a6a670eaef89267cc44d2e4e28ad8ce5f436cde308b3c3"
    }
  },
  {
    "ts": null,
    "headline": "Biopsy Devices Market: Key Players Analysis Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts",
    "summary": "The Biopsy Devices market is projected to reach $4.02 billion by 2033, growing from $2.43 billion in 2024 at a CAGR of 5.75%. This growth is driven by personalized care demand, rising cancer cases, and minimally invasive treatments enhancing patient comfort. Key biopsy devices include needle, punch, and surgical tools for various medical needs. Advancements in biopsy technology ensure precise, early cancer detection and improved patient outcomes. Leading companies like Cardinal Health, Hologic,",
    "url": "https://finnhub.io/api/news?id=327b66287fb9b94011c8a210cc9102372ceccbbc561cab2c90573aa89a0961a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762784220,
      "headline": "Biopsy Devices Market: Key Players Analysis Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts",
      "id": 137395059,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "The Biopsy Devices market is projected to reach $4.02 billion by 2033, growing from $2.43 billion in 2024 at a CAGR of 5.75%. This growth is driven by personalized care demand, rising cancer cases, and minimally invasive treatments enhancing patient comfort. Key biopsy devices include needle, punch, and surgical tools for various medical needs. Advancements in biopsy technology ensure precise, early cancer detection and improved patient outcomes. Leading companies like Cardinal Health, Hologic,",
      "url": "https://finnhub.io/api/news?id=327b66287fb9b94011c8a210cc9102372ceccbbc561cab2c90573aa89a0961a7"
    }
  }
]